4//SEC Filing
Cislini Jeff 4
Accession 0001610717-24-000518
CIK 0001628171other
Filed
Nov 7, 7:00 PM ET
Accepted
Nov 8, 4:20 PM ET
Size
8.1 KB
Accession
0001610717-24-000518
Insider Transaction Report
Form 4
Cislini Jeff
General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-11-06$36.57/sh+6,000$219,420→ 51,634 total - Sale
Common Stock
2024-11-06$60.00/sh−6,000$360,000→ 45,634 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-11-06−6,000→ 30,000 totalExercise: $36.57From: 2024-06-15Exp: 2030-06-16→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 20, 2024.
- [F2]Includes 40,209 restricted stock units.
Documents
Issuer
Revolution Medicines, Inc.
CIK 0001628171
Entity typeother
Related Parties
1- filerCIK 0001969082
Filing Metadata
- Form type
- 4
- Filed
- Nov 7, 7:00 PM ET
- Accepted
- Nov 8, 4:20 PM ET
- Size
- 8.1 KB